ankyrin 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| mitotic cytokinesis |
|
|
| plasma membrane organization |
|
|
| cytoskeleton organization |
|
|
| signal transduction |
|
|
| axonogenesis |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm |
|
|
| lysosome |
|
|
| lysosome |
|
|
| endoplasmic reticulum |
|
|
| Golgi apparatus |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| structural constituent of cytoskeleton |
|
|
| structural constituent of cytoskeleton |
|
|
| protein binding |
|
|
| cytoskeletal protein binding |
|
|
| cytoskeletal anchor activity |
|
| InterPro |
|---|
| Ankyrin repeat-containing domain superfamily |
| Ankyrin repeat |
| Ankyrin, UPA domain |
| Death domain |
| Death-like domain superfamily |
| ZU5 domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0081202 | autosomal recessive intellectual developmental disorder 37 | |
| DOID:3312 | bipolar disorder | |
| DOID:5419 | schizophrenia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026